All News

The next-gen molecular Metrix was given emergency use authorization for its ability to test for SARS-CoV-2 and influenza A and B viruses.

Yesintek from Biocon Biologics and Pyzchiva from Sandoz will have a patient assistance program that includes benefits verification and copay support.

The updated label also includes alternative injection sites, such as the abdomen, thigh, buttock, or back of the upper arm.

Researchers explore the unification of outpatient practices and the structural racism in large health systems that has caused patient disparities.

Researchers identified factors contributing to Medicaid Managed Care complexities and collected evidence of pharmacists’ ability to address patients’ health needs.

The study authors report that long-term daily administration of amlodipine induced behavioral changes in the rats during their open field test.

Pharmacists who participated in the mental health first aid training had better understanding of mental health conditions and increased confidence and skills in mental health intervention.

Ctexli is the first FDA-approved treatment for adults with cerebrotendinous xanthomatosis.

Semaglutide has been in shortage since 2022 due to increased demand.

Measles is highly contagious, and the Texas Department of State Health Services said that additional cases are likely to occur in Gaines County, which had 57 cases as of February 21, 2025.

Experts gathered to explore the pathophysiology and therapeutic management of burn injury-induced pain.

Tirzepatide (Mounjaro, Zepbound), a glucagon-like peptide-1 (GLP-1) medication, demonstrates improved diabetes control and decreases in insulin requirements.

A program that includes peer coaching and monitoring tools can help pharmacists better manage hypertension in patients.

From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.

Researchers conducted a literature review to explore topics in entrepreneurship that impact pharmacy practice and education.

A recent metanalysis found that patients with type 1 diabetes had a 50% higher chance of developing dementia.

By 12 weeks, investigators report that SkinTE facilitated significantly more wound closures compared with the standard of care.

Recently, the FDA alerted users of missed notifications for continuous glucose monitoring devices and Bluetooth smartphone compatibility.

A conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.

Researchers measured current pharmacy practices and the future potential of practices geared toward reducing instances of opioid overdose.

Researchers conducted a survey of community pharmacists to understand their use, concerns, and opportunities regarding ChatGPT technology in their practice setting.

The FDA also granted priority review, with a Prescription Drug User Fee Act target action date of August 19, 2025.

ASC30, an investigational glucagon-like 1-peptide receptor agonist, demonstrates mean weight reductions from baseline of 4.3% and 6.3% for 2 separate cohorts.

A PDUFA target action date for the PrEP therapy has been set for June 19, 2025.

Patients with musculoskeletal pain were treated with cryotherapy spray to assess its use in providing immediate and sustained pain relief.

How pharmacies will pay for the Medicare Drug Price Negotiation Program

The FDA initially approved deucravacitinib (Sotyktu) in September 2022 to treat moderate-to-severe plaque psoriasis.

Explore key legislative actions changing pharmacy practice in 2025 and beyond.